SCHEMBL8902823

SCHEMBL8902823

CC(=O)Oc1c2c(cc3ccccc13)C(=O)C1=C(C2=O)C(C)OC(C(=O)O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
CTH P32929 1/20 0.39
DNMT3B Q9UBC3 1/20 0.39
HSP90AA1 P07900 1/20 0.39
PAX8 Q06710 1/20 0.39
TCF4 P15884 1/20 0.39
CTNNB1 P35222 1/20 0.39
ADORA3 P0DMS8 2/20 0.34
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
KDM4E B2RXH2 5/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
PKM P14618 1/20 0.32
BACE1 P56817 1/20 0.31
KMT2A Q03164 3/20 0.31
GAA P10253 2/20 0.31
MAPT P10636 2/20 0.31
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8902595 0.96 CTH (0.36) IDO1CTHDNMT3BHSP90AA1PAX8
SCHEMBL8902603 0.88 AKT1 (0.36) IDO1CTHDNMT3BHSP90AA1PAX8
SCHEMBL8901558 0.85 DNMT3B (0.44) IDO1CTHDNMT3BHSP90AA1PAX8
SCHEMBL8902846 0.84 AKT1 (0.33) ADORA3ADORA2AADORA1KDM4ENPC1
SCHEMBL9755764 0.82 ADORA3 (0.35) ADORA3ADORA2AADORA1KDM4ENPC1
SCHEMBL8901769 0.81 NQO1 (0.41) IDO1CTHDNMT3BHSP90AA1PAX8
SCHEMBL8903519 0.79 NR1D1 (0.33) CTHADORA3ADORA2AADORA1KDM4E
SCHEMBL8903221 0.79 NR1D1 (0.33) CTHADORA3ADORA2AADORA1KDM4E
SCHEMBL8901727 0.77 KDM4E (0.34) ADORA3ADORA2AADORA1KDM4ENPC1
SCHEMBL9755801 0.77 KDM4E (0.34) IDO1CTHDNMT3BHSP90AA1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed